“Altru Health System historically enrolled four percent of our cancer patient population in clinical trials. Our partnership with Paradigm and our Research Department’s implementation of industry leading best practices increased this enrollment to 11% of the population. This has a profound impact on patients’ lives in a rural community that otherwise would not have access to clinical research as a care option."
First-of-its Kind Collaboration to Transform Clinical Trials in IsraelTogether, Sheba Medical Center, ARC Innovation and Paradigm have launched a collaboration to transform clinical trials with an AI-driven platform that can be deployed at Sheba to streamline their trials, and scale them to any research site throughout Israel. |
Paradigm Partners with Fujitsu to Solve Clinical Trials in JapanThe collaboration reduces the administrative burden of clinical trial participation for Japanese hospitals, expands patient access, and provides global pharmaceutical companies with a streamlined path to world-class hospitals to accelerate the development of new therapies. |
“Highlands has increased clinical trial patient enrollment by 45% over the last two years, while also reducing the burden on the research department. These accomplishments were achieved through the deployment of industry leading best practices, technology, and automations, including Paradigm, who has served as an invaluable partner for our research program.”
“The accuracy of OpenAI was better than our existing deployment and optimization of industry best-practice expert-trained models, and it was sometimes better than our trained clinicians. The more complex the information, and the more different places that information sat, the better GPT-4 was.”